PR89959

BRESCIA, Italy, June 8, 2021 /PRNewswire=KYODO JBN/ --

Copan announces a $78 million investment to expand its Puerto Rican production

site. The project – partially financed by Puerto Rico's Government – will bring

Copan production and distribution capacity closer to the American market,

strengthening the company's presence in the US and the rest of the Americas.

Copan Group announced a millionaire investment to expand its production

capacity in Aguadilla, Puerto Rico, which joined the main Italian production

site three years ago. The operation has a total value of over $ 78 million: $9

million will be allocated to purchase and maintain new machinery, while the

rest will be invested to increase the number of employees from 100 to 352.

"The establishment of our company in Puerto Rico has proven to provide

favorable conditions for the expansion and growth of our business globally,"

declared Stefania Triva, Copan Group's President. "With this investment, we aim

to strengthen our presence in the US market: through a hub & spoke distribution

strategy, we'll be able to offer a competitive service with unprecedented

efficiency and rapidity throughout all the American territory," she continues.

Puerto Rico's Economic Development and Commerce Department supported the

operation by approving $23 million of incentives, seeing in the project – which

brings Copan's technological know-how, quality, and work welfare attitude

across the ocean – an excellent opportunity for the whole US. According to

Puerto Rican Governor Pedro Pierluisi, "manufacturing companies as Copan

represent an important component of the economy, as they contribute to creating

and retaining jobs. We are proud of the talent that exists in Puerto Rico, and

we are confident in the continued success and commitment of Copan Industries to

the Island."

Copan's recent activity has been fervent in the US, with investments in Puerto

Rico, California, and the successful clearance of products finally available in

the US – as the eNAT (R) nucleic acid storage and stabilization device

FDA-cleared at the end of 2020. This project fits Copan's current strategy to

bring production sites closer to the end markets, streamlining logistics and

enabling an efficient and prompt service everywhere globally.

About Copan

Copan is dedicated to developing high-quality and cutting-edge sample

collection products for infectious diseases, human genomics, environmental and

forensic applications, along with automated workflow solutions. Our ideas drove

40 years of progress in the field of preanalytics, resulting in the development

of meaningful products tailored to fit any need. Among them, our patented

FLOQSwabs (R) reinvented completely sample collection and transport, while the

WASPLab (R) automation ecosystem revolutionized laboratory workflow. Today,

Copan is still eager to continue this innovation, providing quality products,

customized services, and prime solutions to improve patients' health.

Photo - https://mma.prnewswire.com/media/1527451/Copan_Puerto_Rico.jpg

Logo - https://mma.prnewswire.com/media/1484615/CopanHD_Logo.jpg

Source: Copan Italia SpA